Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

BlueWind Medical, a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of Revi®, a patient-centric ...

In CBS’ ‘Survivor 47,’ a new group of ambitious individuals gathered in Fiji to put their physical and mental abilities to ...

Scott is a MedTech veteran who has held leadership positions at Smith & Nephew Ioptex (Ophthalmology), and Covidien Surgical Device, today Medtronic. Scott has previously, among other things ...

Neurointerventional Devices Market is likely to reach US$ 4.1 billion by 2033. The market is further expected to surge at a ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).